Compare Equinix Inc (EQIX) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinix Inc vs Stryker Corporation — how do they compare? Equinix Inc trades at $1,027.6 (market cap $99.77B), while Stryker Corporation trades at $277.34 (market cap $106.24B). The key difference: Equinix Inc and Stryker Corporation are close in size by market cap, and Equinix Inc pays the higher dividend (2.04%). Which is the better fit depends on your goals — on Pluang, investors hold Equinix Inc for 110 Days and Stryker Corporation for 21 Days on average.
| EQIX | SYK | |
|---|---|---|
Market Cap | $99.77B | $106.24B |
Volume | 480,425 | 2,982,001 |
Sector | Real Estate | Health |
52-Week High | $1.12K | $388.35 |
52-Week Low | $726.09 | $269.75 |
Typical Hold Time | 110 Days | 21 Days |
Enterprise Value | $120.90B | $117.70B |
Dividend Yield | 2.04% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equinix (EQIX) trades at $1,026.06, down 0.55% on the day, amid a bearish technical signal. The stock shows strong fundamentals with revenue growth from $9.22B in 2025 to a projected $9.8B in 2026 and a net income margin of 15.63%. Recent earnings saw a mix of beats and misses, with Q2 2026 EPS of $4.83 exceeding expectations. Analyst sentiment remains overwhelmingly positive with a 75.47% buy rating and a consensus price target of $1,250.
The outlook for EQIX is supported by robust AI-driven data center demand and a $5B-$7B annual expansion plan, but risks include high valuation multiples (P/E of 65.07) and significant capital expenditures leading to negative cash flow. The stock presents a growth opportunity tied to digital infrastructure trends, though investors should weigh elevated debt levels and execution risks against long-term potential.
Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.
The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equinix Inc
Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
